MSU
VRTX icon

Mizuho Securities USA’s Vertex Pharmaceuticals VRTX Stock Holding History

Mizuho Securities USA’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.87M Buy
19,870
+4,515
+29% +$2M 0.16% 107
2026
Q1 		$6.86M Sell
15,355
-3,119
-17% -$1.45M 0.16% 130
2025
Q4 		$8.01M Sell
18,474
-200
-1% -$86.2K 0.13% 128
2025
Q3 		$7.3M Buy
18,674
+924
+5% +$386K 0.15% 130
2025
Q2 		$7.9M Sell
17,750
-2,811
-14% -$1.3M 0.17% 115
2025
Q1 		$9.97M Sell
20,561
-3,847
-16% -$1.79M 0.22% 96
2024
Q4 		$9.83M Buy
24,408
+7,671
+46% +$3.56M 0.18% 103
2024
Q3 		$7.78M Sell
16,737
-3,159
-16% -$1.52M 0.17% 99
2024
Q2 		$9.33M Buy
+19,896
New +$8.64M 0.21% 92
2015
Q2 		– Sell
-6,961
Closed -$821K – 256
2015
Q1 		$821K Sell
6,961
-223
-3% -$26.7K 0.11% 116
2014
Q4 		$853K Buy
7,184
+3,038
+73% +$342K 0.08% 111
2014
Q3 		$466K Buy
+4,146
New +$395K 0.05% 94
2014
Q1 		– Sell
-28,240
Closed -$2.1M – 109
2013
Q4 		$2.1M Buy
28,240
+8,153
+41% +$568K 0.17% 81
2013
Q3 		$1.52M Sell
20,087
-2,252
-10% -$179K 0.1% 81
2013
Q2 		$1.78M Buy
+22,339
New +$1.65M 0.09% 76

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Mizuho Securities USA's VRTX Position: Q2 2026 in Review

Mizuho Securities USA increased its Vertex Pharmaceuticals (VRTX) stake by 29% in Q2 2026, buying an estimated $2M and bringing the position to 19,870 shares worth $9.87M. The position accounts for 0.16% of the portfolio, ranked #107.

Mizuho Securities USA first reported a position in VRTX in Q2 2013 and has held it in 15 quarters since. The position peaked at $9.97M in Q1 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Mizuho Securities USA held 19,870 shares of Vertex Pharmaceuticals worth $9.87M as of Q2 2026.
  • Mizuho Securities USA bought 4,515 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2M.
  • Vertex Pharmaceuticals made up 0.16% of Mizuho Securities USA's portfolio in Q2 2026, its #107 holding.
  • Mizuho Securities USA first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • Mizuho Securities USA's Vertex Pharmaceuticals position peaked at $9.97M in Q1 2025.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Mizuho Securities USA's 13F filing for Q2 2026, filed 24 Jul 2026.